These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32747940)

  • 1. Treatment efficacy for pharyngeal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials.
    Kong FYS; Hatzis CL; Lau A; Williamson DA; Chow EPF; Fairley CK; Hocking JS
    J Antimicrob Chemother; 2020 Nov; 75(11):3109-3119. PubMed ID: 32747940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials.
    Lo FWY; Kong FYS; Hocking JS
    J Antimicrob Chemother; 2021 Nov; 76(12):3111-3124. PubMed ID: 34458921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial.
    Rob F; Klubalová B; Nyčová E; Hercogová J; Unemo M
    Clin Microbiol Infect; 2020 Feb; 26(2):207-212. PubMed ID: 31419483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
    Ross JD; Harding J; Duley L; Montgomery AA; Hepburn T; Tan W; Brittain C; Meakin G; Sprange K; Thandi S; Jackson L; Roberts T; Wilson J; White J; Dewsnap C; Cole M; Lawrence T
    Health Technol Assess; 2019 May; 23(20):1-104. PubMed ID: 31099330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
    Chen MY; McNulty A; Avery A; Whiley D; Tabrizi SN; Hardy D; Das AF; Nenninger A; Fairley CK; Hocking JS; Bradshaw CS; Donovan B; Howden BP; Oldach D;
    Lancet Infect Dis; 2019 Aug; 19(8):833-842. PubMed ID: 31196813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L;
    Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
    Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
    Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aztreonam for Neisseria gonorrhoeae: a systematic review and meta-analysis.
    Barbee LA; Golden MR
    J Antimicrob Chemother; 2020 Jul; 75(7):1685-1688. PubMed ID: 32259846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin in the treatment of infection with Neisseria gonorrhoeae.
    Bignell C; Garley J
    Sex Transm Infect; 2010 Nov; 86(6):422-6. PubMed ID: 20940153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
    Hustig A; Bell C; Waddell R
    Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.
    Unemo M; Lahra MM; Cole M; Galarza P; Ndowa F; Martin I; Dillon JR; Ramon-Pardo P; Bolan G; Wi T
    Sex Health; 2019 Sep; 16(5):412-425. PubMed ID: 31437420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials.
    Bai ZG; Bao XJ; Cheng WD; Yang KH; Li YP
    Int J STD AIDS; 2012 Feb; 23(2):126-32. PubMed ID: 22422688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trend analysis (2009-2016) of antimicrobial susceptibility in Neisseria gonorrhoeae isolated in Italy following the introduction of the combined antimicrobial therapy.
    Stefanelli P; Vescio MF; Landini MP; Dal Conte I; Matteelli A; Cristaudo A; Gaino M; Cusini M; Barbui AM; Mencacci A; De Nittis R; Ghisetti V; Stroppiana E; Carannante A;
    PLoS One; 2017; 12(12):e0189484. PubMed ID: 29240786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
    Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
    Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.
    Unemo M; Golparian D; Eyre DW
    Methods Mol Biol; 2019; 1997():37-58. PubMed ID: 31119616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.